ロード中...
Effects of impaired renal function on the pharmacokinetics of raltitrexed (Tomudex ZD1694).
This open-label, non-randomized, parallel-group trial investigated the pharmacokinetics of raltitrexed (Tomudex, formerly ZD1694) after a single intravenous dose of 3.0 mg m(-2), comparing eight cancer patients with mild to moderate renal impairment (creatinine clearance 25-65 ml min(-1)) with eight...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group|1
1998
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2062997/ https://ncbi.nlm.nih.gov/pubmed/9820178 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|